4//SEC Filing
Franchini Indrani Lall 4
Accession 0001735276-24-000016
CIK 0001178670other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:16 PM ET
Size
16.5 KB
Accession
0001735276-24-000016
Insider Transaction Report
Form 4
Franchini Indrani Lall
EVP, CLO & Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-27−878→ 1,754 totalExp: 2026-02-27→ Common Stock (878 underlying) - Sale
Common Stock
2024-02-28$154.54/sh−142$21,945→ 4,320 total - Sale
Common Stock
2024-02-28$156.38/sh−66$10,321→ 4,143 total - Exercise/Conversion
Common Stock
2024-02-27+878→ 4,462 total - Sale
Common Stock
2024-02-28$155.45/sh−111$17,255→ 4,209 total - Sale
Common Stock
2024-02-28$157.30/sh−9$1,416→ 4,134 total - Sale
Common Stock
2024-02-28$158.09/sh−1$158→ 4,133 total
Footnotes (8)
- [F1]Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $153.94 to $154.94. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $154.95 to $155.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $155.96 to $156.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $157.01 to $157.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
- [F7]The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.
- [F8]On February 27, 2023, the reporting person was granted 2,632 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2024, the first tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001708764
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:16 PM ET
- Size
- 16.5 KB